Answers are grounded in this paper and cite their sources.
Shows in vivo T1 mapping detects significantly lower intraplaque T1 values in symptomatic patients, highlighting 3D GOAL-SNAP as a promising tool for intracranial plaque characterization.
T1 mapping could provide more reliable quantitative measurements of plaques than traditional T1w MR images. In this study, the feasibility of in vivo quantitative T1 mapping of intracranial plaque had been demonstrated for the first time using a 3D SNAP with golden angle radial k-space sampling (GOAL-SNAP) sequence. Symptomatic patients showed significantly lower intraplaque T1 values than asymptomatic patients (1695.21 ± 493.23 vs. 2241.76 ± 300.28 ms, p=0.045). Quantifying plaque T1 values and enhancement through 3D GOAL-SNAP T1 mapping images is promising for characterizing the symptomatic plaques, serving as one potential tool for further plaque analysis.
No takes yet. Share an insight, caveat, or question.
Dou et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: